Percutaneous Coronary Intervention Complications and Guide Catheter Size. Bigger Is Not Better

JACC: Cardiovascular Interventions

Volumn 2, Issue 7, 2009, Pages 636-644

  Grossman, P Michael ^a,b   Gurm, Hitinder S ^a,b   McNamara, Richard ^c   LaLonde, Thomas ^d   Changezi, Hameem ^e   Share, David ^a   Smith, Dean E ^a   Chetcuti, Stanley J ^a,b   Moscucci, Mauro ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c SPECTRUM HEALTH   (United States)

^d ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

^e GENESYS REGIONAL MEDICAL CENTER   (United States)

Author keywords

coronary guide catheter size; coronary intervention complications; coronary intervention outcomes; percutaneous coronary intervention

Indexed keywords

CONTRAST MEDIUM; HEMOGLOBIN;

ADULT; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BLOOD VESSEL INJURY; CATHETER COMPLICATION; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIALYSIS; FEMALE; HEART CATHETER; HEART CATHETERIZATION; HEART DISEASE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; VASCULAR ACCESS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; BLOOD TRANSFUSION; CONTRAST MEDIA; EQUIPMENT DESIGN; FEMALE; HEART DISEASES; HEMORRHAGE; HOSPITAL MORTALITY; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; ODDS RATIO; REGISTRIES; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 67650638844     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.05.012     Document Type: Article

References (34)

1. Lee P.C., Kini A.S., Ahsan C., Fisher E., and Sharma S.K. Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol 44 (2004) 541-546
2. Guagliumi G., Stone G.W., Cox D.A., et al. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. Circulation 110 (2004) 1598-1604
3. Berger J.S., Sanborn T.A., Sherman W., and Brown D.L. Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention. Am J Cardiol 94 (2004) 649-651
4. Cheng C.I., Yeh K.H., Chang H.W., et al. Comparison of baseline characteristics, clinical features, angiographic results, and early outcomes in men vs women with acute myocardial infarction undergoing primary coronary intervention. Chest 126 (2004) 47-53
5. McKechnie R.S., Smith D., Montoye C., et al. Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation 110 (2004) 271-277
6. Lansky A.J., Mehran R., Dangas G., et al. Comparison of differences in outcome after percutaneous coronary intervention in men versus women <40 years of age. Am J Cardiol 93 (2004) 916-919
7. Mehran R., Dangas G.D., Kobayashi Y., et al. Short- and long-term results after multivessel stenting in diabetic patients. J Am Coll Cardiol 43 (2004) 1348-1354
8. Watanabe C.T., Maynard C., and Ritchie J.L. Short-term outcomes after percutaneous coronary intervention: effects of stenting and institutional volume shifts. Am Heart J 144 (2002) 310-314
9. Harjai K.J., Berman A.D., Grines C.L., et al. Impact of interventionalist volume, experience, and board certification on coronary angioplasty outcomes in the era of stenting. Am J Cardiol 94 (2004) 421-426
10. Halm E.A., Lee C., and Chassin M.R. Is volume related to outcome in health care?. A systematic review and methodologic critique of the literature. Ann Intern Med 137 (2002) 511-520
11. Wennberg D.E., Lucas F.L., Siewers A.E., Kellett M.A., and Malenka D.J. Outcomes of percutaneous coronary interventions performed at centers without and with onsite coronary artery bypass graft surgery. JAMA 292 (2004) 1961-1968
12. Ho V. Certificate of need, volume, and percutaneous transluminal coronary angioplasty outcomes. Am Heart J 147 (2004) 442-448
13. Kline-Rogers E., Share D., Bondie D., et al. Development of a multicenter interventional cardiology database: the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) experience. J Interv Cardiol 15 (2002) 387-392
14. Moscucci M., Share D., Kline-Rogers E., et al. The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) collaborative quality improvement initiative in percutaneous coronary interventions. J Interv Cardiol 15 (2002) 381-386
15. D'Agostino Jr. R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
16. Parson L. Reducing bias in a propensity score matched-pair sample using Greedy matching techniques. Proceedings of the 26th Annual SAS Users Group International Conference (2001), SAS Institute, Cary, NC 214-226
17. Gurm H.S., Smith D.E., Collins J.S., et al. The relative safety and efficacy of abciximab and eptifibatide in patients undergoing primary percutaneous coronary intervention: insights from a large regional registry of contemporary percutaneous coronary intervention. J Am Coll Cardiol 51 (2008) 529-535
18. Allison P.D., and SAS Institute. Logistic Regression Using the SAS System: Theory and Application (1999), SAS Institute, Cary, NC
19. Austin P.C. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med 27 (2008) 2037-2049
20. Freeman R.V., O'Donnell M., Share D., et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 90 (2002) 1068-1073
21. Shishehbor M.H., Topol E.J., Mukherjee D., et al. Outcome of multivessel coronary intervention in the contemporary percutaneous revascularization era. Am J Cardiol 97 (2006) 1585-1590
22. Bartholomew B.A., Harjai K.J., Dukkipati S., et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 93 (2004) 1515-1519
23. Yang X., Alexander K.P., Chen A.Y., et al. The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 46 (2005) 1490-1495
24. Krieger R.A., Furst A.E., Hildner F.J., Midwall J., and Kieval J. CO2 power-assisted hand-held syringe: better visualization during diagnostic and interventional angiography. Cathet Cardiovasc Diagn 19 (1990) 123-128
25. Dodge Jr. J.T., Nykiel M., Altmann J., Hobkirk K., Brennan M., and Gibson C.M. Coronary artery injection technique: a quantitative in vivo investigation using modern catheters. Cathet Cardiovasc Diagn 44 (1998) 34-39
26. Omoigui N.A., Califf R.M., Pieper K., et al. Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I). J Am Coll Cardiol 26 (1995) 922-930
27. Aronow H.D., Peyser P.A., Eagle K.A., et al. Predictors of length of stay after coronary stenting. Am Heart J 142 (2001) 799-805
28. Kugelmass A.D., Cohen D.J., Brown P.P., Simon A.W., Becker E.R., and Culler S.D. Hospital resources consumed in treating complications associated with percutaneous coronary interventions. Am J Cardiol 97 (2006) 322-327
29. Fransson S.G., and Nylander E. Vascular injury following cardiac catheterization, coronary angiography, and coronary angioplasty. Eur Heart J 15 (1994) 232-235
30. Muller D.W., Shamir K.J., Ellis S.G., and Topol E.J. Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures. Am J Cardiol 69 (1992) 63-68
31. Farouque H.M., Tremmel J.A., Raissi Shabari F., et al. Risk factors for the development of retroperitoneal hematoma after percutaneous coronary intervention in the era of glycoprotein IIb/IIIa inhibitors and vascular closure devices. J Am Coll Cardiol 45 (2005) 363-368
32. Juergens C.P., Hallani H., Leung D.Y., et al. Comparison of 6 and 7 French guiding catheters for percutaneous coronary intervention: results of a randomised trial with a vascular ultrasound endpoint. Catheter Cardiovasc Interv 66 (2005) 528-534
33. Piper W.D., Malenka D.J., Ryan Jr. T.J., et al. Predicting vascular complications in percutaneous coronary interventions. Am Heart J 145 (2003) 1022-1029
34. Ellis S.G., and Holmes D.R. Strategic Approaches in Coronary Intervention. 3rd edition (2006), Lippincott Williams & Wilkins, Philadelphia, PA